CMCSA
44
-2
HSY
43
2
FOX
68
2
O
33
2
KR
37
-5
ISRG
71
4
AIV
37
-2
HD
28
-4
F
59
3
CL
58
2
IRM
41
10
CF
48
4
URI
46
3
ETR
47
-2
DHR
66
2
STI
18
11
SE
49
2
AKAM
64
2
AZO
42
-3
LYB
22
2
CMCSA
44
-2
HSY
43
2
FOX
68
2
O
33
2
KR
37
-5
ISRG
71
4
AIV
37
-2
HD
28
-4
F
59
3
CL
58
2
IRM
41
10
CF
48
4
URI
46
3
ETR
47
-2
DHR
66
2
STI
18
11
SE
49
2
AKAM
64
2
AZO
42
-3
LYB
22
2
Financhill
Back

Calamos Nasdaq Equity & Income ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
41

CANQ
Calamos Nasdaq Equity & Income ETF

Last Price:
$29.91
Seasonality Move:
3.16%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Sell
41
Calamos Nasdaq Equity & Income ETF (CANQ) is a Sell

Is Calamos Nasdaq Equity & Income ETF a Buy, Sell or Hold?

  • The current Calamos Nasdaq Equity & Income ETF [CANQ] share price is $29.90. The Score for CANQ is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CANQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CANQ Stock Price Chart

What is Calamos Nasdaq Equity & Income ETF's stock price today?

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

CANQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 42.53 Sell
Chaikin Money Flow: -6745 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.92 - 30.52) Sell
Bollinger Bands (100): (29.41 - 30.57) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

CANQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.01 Sell
20-day SMA: 30.26 Sell
50-day SMA: 30.38 Sell
200-day SMA: 28.73 Buy
8-day EMA: 29.97 Sell
20-day EMA: 30.17 Sell
50-day EMA: 29.71 Buy
200-day EMA: 19.13 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Calamos Nasdaq Equity & Income ETF Earnings Growth & CANQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Calamos Nasdaq Equity & Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):